U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 8681 - 8690 of 9908 results

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Canada:CHIMAPHILA MACULATA
Source URL:

Class:
STRUCTURALLY DIVERSE

Group 1 Specified Substance
Status:
Investigational
Source:
INN:velucovacap [INN]
Source URL:

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
Investigational
Source:
NCT00255827: Phase 1/Phase 2 Interventional Completed Pancreatic Cancer
(2005)
Source URL:

Class:
G1 SPECIFIED SUBSTANCE

Group 1 Specified Substance
Status:
Investigational
Source:
INN:belzupacap sarotalocan [INN]
Source URL:

Class:
G1 SPECIFIED SUBSTANCE

Concept
Status:
Investigational
Source:
NCT04203641: Phase 1/Phase 2 Interventional Active, not recruiting Pancreas Cancer
(2019)
Source URL:

Class:
CONCEPT

Concept
Status:
Investigational
Source:
INN:rezuforimod [INN]
Source URL:

Class:
CONCEPT

Concept
Status:
Other

Class:
CONCEPT

Showing 8681 - 8690 of 9908 results